# The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis

> **NCT05356793** · PHASE2 · COMPLETED · sponsor: **Sacsh** · enrollment: 30 (actual)

## Conditions studied

- Acute Infectious Conjunctivitis (Disorder)

## Interventions

- **DRUG:** SCH-1
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05356793
- **Lead sponsor:** Sacsh
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2022-03-28
- **Final completion:** 2022-03-28
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05356793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05356793, "The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05356793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*